The landscape of modern medicine is being fundamentally reshaped as the industry moves from treating symptoms to addressing the root genetic causes of disease. Current RNA-Based Therapeutics Market Demands are shifting beyond the realm of rare genetic disorders and into the massive global burden of chronic conditions. While early breakthroughs focused on oncology and infectious diseases,...

According to a new report by Expert Market Research, the RNA Therapeutics Market was valued at USD 15.28 Billion in 2025 and is projected to reach USD 26.35 Billion by 2035, expanding at a CAGR of 5.6% during 2026–2035. The RNA Therapeutics Market is witnessing strong momentum supported by advancements in mRNA, RNA interference, and antisense technologies, with growing investments from...

Small Interfering RNA (siRNA) Therapeutics Market Set to Surge as Precision Gene-Silencing Treatments Gain Momentum Small Interfering RNA (siRNA) Therapeutics Market is rapidly transitioning into a cornerstone of next-generation medicine, with the market expected to reach around USD 39.19 billion by 2032, driven by the rising incidence of genetic and chronic diseases, and accelerating...

Small interfering RNA therapeutics — the double-stranded RNA molecules of approximately twenty-one to twenty-three nucleotides that trigger RNA interference silencing specific disease-causing genes through the RISC (RNA-induced silencing complex) pathway — represent one of the most transformative pharmaceutical modalities in modern medicine, with the Small Interfering RNA Market...

The RNA analysis market is entering a strong growth phase as transcriptomic research, precision medicine, drug discovery, and RNA-based therapeutics increase demand for advanced molecular analysis. The market was valued at USD 9.2 billion in 2025 and is projected to grow from USD 9.9 billion in 2026 to USD 23.6 billion by 2033, registering a 13.3% CAGR from 2026 to 2033. The expansion reflects...